Overview
Matthias Karajannis is an Oncologist practicing medicine in New York, New York.
Dr. Karajannis is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Glioma, Medulloblastoma, and Brain Stem Cancer.
He is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 8 clinical trials. Dr. Karajannis is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
1275 York Ave, New York, NY 10065
Additional Areas of Focus
Dr. Karajannis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Matthias Karajannis
How do I make an appointment with Dr. Matthias Karajannis?
You can book an appointment with Dr. Matthias Karajannis by calling their office at 646-535-4990. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthias Karajannis a top-rated expert for Neurofibromatosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthias Karajannis is classified as an Distinguished expert for Neurofibromatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthias Karajannis specialize in?
While Dr. Matthias Karajannis is a Oncology, they have specific expertise in Neurofibromatosis, Glioma, and Medulloblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Matthias Karajannis participate in research or clinical trials?
Yes. Dr. Matthias Karajannis has published 117 articles and abstracts on conditions like Neurofibromatosis. You can view a list of Dr. Matthias Karajannis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthias Karajannis accept my insurance?
Dr. Matthias Karajannis accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 646-535-4990 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GliomaDr. Karajannis isDistinguished. Learn about Glioma.
- MedulloblastomaDr. Karajannis isDistinguished. Learn about Medulloblastoma.
- NeurofibromatosisDr. Karajannis isDistinguished. Learn about Neurofibromatosis.
- Advanced
- Brain Stem CancerDr. Karajannis isAdvanced. Learn about Brain Stem Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Karajannis isAdvanced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- Embryonal Tumor with Multilayered Rosettes
- Optic GliomaDr. Karajannis isAdvanced. Learn about Optic Glioma.
- PineoblastomaDr. Karajannis isAdvanced. Learn about Pineoblastoma.
- PineocytomaDr. Karajannis isAdvanced. Learn about Pineocytoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Karajannis isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ewing SarcomaDr. Karajannis isExperienced. Learn about Ewing Sarcoma.
- GangliogliomaDr. Karajannis isExperienced. Learn about Ganglioglioma.
- Hereditary RetinoblastomaDr. Karajannis isExperienced. Learn about Hereditary Retinoblastoma.
- Infantile NeutropeniaDr. Karajannis isExperienced. Learn about Infantile Neutropenia.
- Legius SyndromeDr. Karajannis isExperienced. Learn about Legius Syndrome.